Education & Training
- PhD: Counseling Psychology: Washington University, St. Louis, MO, 1978
- BA: Psychology: University of Missouri, St. Louis, MO, 1969
Major Awards
- Wayne Katon Research Award, Academy of Psychosomatic Medicine, 2017
- Fellow, Academy of Cognitive Therapy, 1999
- Fellow, Society of Behavioral Medicine, 1998
- Fellow, Academy of Behavioral Medicine Research, 1998
- Visiting Scholar, American Psychosomatic Society, 1994
Areas of Clinical Interest
Certified cognitive therapist, depression in cardiac patients, behavioral cardiovascular disease prevention
Research Interests
Depression in cardiovascular disease
Key Publications
- Carney RM, Freedland KE, (2017 Mar). Depression and coronary heart disease. Nat Rev Cardiol. 14(3): 145-155.
Read publication »Depression and coronary heart disease. - Carney RM, Freedland KE, Steinmeyer BC, Rubin EH, Stein PK, Rich MW, (2016 08). Nighttime heart rate predicts response to depression treatment in patients with coronary heart disease. J Affect Disord. 200: 165-71.
Read publication »Nighttime heart rate predicts response to depression treatment in patients with coronary heart disease. - Carney RM, Freedland KE (2012 Feb). Is there a high-risk subtype of depression in patients with coronary heart disease? Curr Psychiatry Rep. 14:1-7.
Read publication »Is there a high-risk subtype of depression in patients with coronary heart disease? - Carney RM, Freedland KE (2012 Jan). Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? Psychosom Med. 74(1):33-38.
Read publication »Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? - Roest AM, Carney RM, Stein PK, Freedland KE, Meyer H, Steinmeyer BC, de Jonge P, Rubin EH (2012 Jan). Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease. J Clin Psychiatry. 73(1): 31-6.
Read publication »Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease. - Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS (2009 Oct 21). Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 302(15): 1651-7.
Read publication »Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Funded Research Projects
NHLBI(PI):Omega-3 for Depression and Other Cardiac Risk Factors
NIDA(Significant Contributor):Genetically Informed Smoking Cessation Trial
NHLBI(Significant Contributor):Stepped Care for Depression in Heart Failure
NHLBI(Key Personnel):Depression and Rehospitalization in Patients with Heart Failure